Ang2 agonist activity has been reported in the lymphatic vascular bed, tumour vasculature and stressed ECs that have reduced Ang1–Tie2–Akt signalling, leading to feedback up-regulation of the Foxo1 target Ang2 [47,62–64]. The gene discussed is TEK; the disease is neoplasm.